Home » Topics » Disease categories and therapies » Infection

Infection
RSS

FDA approves new indications, dosing regimens for Vantin

Dec. 2, 1998

Improved antibacterial efficacy observed with OPC-20011

Dec. 2, 1998

AMBI seeks partners to develop oral nisin for colon infections

Dec. 1, 1998

New antiparasitic agents in development at Bayer

Dec. 1, 1998

Alkermes, Schering-Plough agree to terminate collaboration

Nov. 30, 1998

Shionogi claims new agents for influenza

Nov. 30, 1998

Antimicrobial and antitumor activity of xenomin compounds described

Nov. 30, 1998

Viral and nonviral serine protease inhibitors developed at Emory University

Nov. 27, 1998

Design, synthesis and antiviral activity of A-5021 discussed this week in Kyoto

Nov. 26, 1998

Preliminary results announced for pleconaril pediatric study; other trials in progress

Nov. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...